Drugs and Devices

FDA approves new drug for severe drooling

On July 28, the U.S. Food and Drug Administration (FDA) approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years. Read more at here.

Related Articles:

Leave a Reply

You have to agree to the comment policy.